Shlomo Assa

A global designer, manufacturer, and seller of energy systems and medical devices for the aesthetic market with revenues of $325 million, with 850 employees in 16 global direct offices, and through 45 regional distributors.
EVP, Chief Technology Officer | 2017 – 2018
Led 120 employees with six direct report vice president-level managers. Administered an annual operating budget of $25 million. Ascribed to build sustained growth for the Syneron and Candela brands.

• $100 million sales predicted by establishing the strategic technology roadmap for using the company core competence radio frequency (RF) technology to develop the first generation of a true fat destruction system, non- invasive aesthetic product and driving the cross functional team developing the platform.
• $60+ million in APAC revenue with 75% gross margin produced by launching Picoway Resolve, a new zero-downtime facial rejuvenation, and best-selling APAC product physicians sold for a $1,500 15 to 20-minute treatment.
• $60 million in sales projected by introducing Vbeam Prima, a best in class pulse dye laser platform for a complete aesthetic and medical laser workstation treating red and blue blood vessels, pigmentation, and skin rejuvenation.
• $60+ million income forecasted by spearheading the invention and development of a new patented epidermal protection contact cooling beam delivery applicator, EverCool, used with Vbeam Prima to extend system functionality and enhance the Vbeam Gold Standard heritage.
• $50 million in revenue growth realized in a market with a compound annual growth rate (CAGR) less than 8% by leading a team to acquire Ellipse, the most innovative intense pulse light (IPL) multi-application platform available.

• 25% R&D cost reduction experienced by consolidating to one global R&D team without geographical boundaries and with the mission to operate as one unit and support the new product development roadmap post-Syneron Candela acquisition by APAX Partners, a private equity firm.
• Built the new medical device regulatory and clinical affair departments by managing the recruitment team to create new regulatory and clinical affairs job description applying a process that included identifying the top talent available in the medical device industry and recruiting 35+ individuals to fill all openings in less than nine months.
• 2% and less retention from voluntary resignation versus an industry standard and acceptable level of less than 8% maintained while reorganizing the company by generating superior productivity levels through a culture empowering success that enabled the company to follow the operation plans without production disruption.

General Manager, Candela | 2013 – 2017
Directed 200 employees with seven VP-level direct reports managing a $50 million budget to expand the Candela brand. Played a critical role in business turnaround, introduced new product innovation strategy, created a global team, and delivered high-quality, innovative products supported by operations excellence.

• $125 million in revenue with margins of 75% achieved in three years by positioning the product developing the value proposition promotion presentations and collaborating with the sales and marketing organization to start the global distribution of the Picoway product, the most Innovative aesthetic Pico second laser platform.
• $15 million in sales, 75%+ gross margin, and a 20% YoY growth rate accomplished by creating the strategic roadmap for Resolve, driving the technology invention, and developing the steps to establish the science behind the product, while focusing the team to turn the patented game changer treatment to a zero-downtime facial rejuvenation.
• 62% gross margin improvement attained while boosting product demand 22% and slashing warranty failure rate to less than 2%, an industry record, by driving quality in every product and service, out of box failure prevention, cost reductions, and a re-marketing of the brand for quality and performance.
• 30% income rise YoY realized by strategically positioning Picoway as the next generation replacement for the Q-Switch laser to clear pigmentation on Asian skin, expand the use of Picoway for Asian skin toning, and steering \the team to deploy the business plan in China, Korea, and India, increasing global market share penetration.

• $20 million in revenue produced by guiding a cross-functional team to develop and launch Gentle Touch, the next generation laser hair removal platform.
• 62% gross margin recorded and 22% product demand expansion attained by analyzing each bill of material, creating a supply chain path to lower component costs, and building quality in every product, boosting the brand equity value.
• 2% voluntary resignations noted by maintaining the highest level of employee retention.